Crohn's & Colitis Foundation Executive and Leadership Team

Michael Osso, the President & Chief Executive Officer at Crohn's & Colitis Foundation, directs the overarching strategic vision for this non-profit organization. Overseeing national research initiatives and patient support programs, the President & Chief Executive Officer ensures alignment between volunteer efforts and medical breakthroughs. This leadership role involves managing complex stakeholder relationships and securing the financial resources necessary to sustain long-term research goals. By fostering partnerships with clinical experts and donors, Michael Osso accelerates the development of innovative treatments for Crohn's disease and ulcerative colitis. The President & Chief Executive Officer maintains a focus on scaling the impact of the organization across North America, ensuring that every patient receives access to high-quality care and advocacy. Through rigorous oversight of organizational performance, Osso drives the mission forward, ultimately improving the quality of life for millions of children and adults suffering from these chronic conditions.

Sharon Lungrin, the Chief Operating Officer at Crohn's & Colitis Foundation, manages the daily operational workflows that sustain the organization's nationwide charitable activities. Overseeing internal processes and resource allocation, the Chief Operating Officer ensures that volunteer-fueled initiatives function with maximum efficiency and transparency. This leadership role involves coordinating cross-departmental projects to support the foundation's core mission of improving patient quality of life. By refining administrative procedures and optimizing operational budgets, Sharon Lungrin enables the organization to direct more funding toward critical research and community support programs. The Chief Operating Officer works closely with regional chapters to standardize service delivery and maintain high levels of engagement across diverse geographic markets. Through consistent monitoring of operational metrics, Lungrin drives organizational excellence, ensuring that every internal function contributes effectively to the ultimate goal of discovering cures for Crohn's disease and ulcerative colitis.

Jeffrey Ward, the Board Member and Board President (Volunteer Position) at Crohn's & Colitis Foundation, provides governance and strategic oversight to ensure the organization remains true to its mission. Overseeing the activities of the Board of Trustees, the Board Member and Board President (Volunteer Position) facilitates high-level decision-making regarding research funding and organizational priorities. This leadership role involves engaging with stakeholders to promote the foundation's goals and secure long-term support for medical breakthroughs. By fostering a culture of accountability and transparency, Jeffrey Ward ensures that the foundation effectively serves the needs of patients affected by Crohn's disease and ulcerative colitis. The Board Member and Board President (Volunteer Position) collaborates with the executive team to align volunteer efforts with professional research initiatives. Through dedicated service, Ward drives the strategic direction of the organization, ensuring that the foundation continues to make significant progress toward finding cures.

Mark Bovenizer, the President of the Board of Trustees - Jersey Chapter at Crohn's & Colitis Foundation, leads regional advocacy and fundraising efforts to support the organization's national mission. Overseeing the local board's activities, the President of the Board of Trustees - Jersey Chapter ensures that community-based programs effectively address the needs of patients in the region. This role involves mobilizing volunteers and organizing local events to raise awareness and funds for research into Crohn's disease and ulcerative colitis. By connecting local patient communities with national resources, Mark Bovenizer enhances the overall impact of the foundation's support services. The President of the Board of Trustees - Jersey Chapter works to build strong relationships with local medical providers and donors, ensuring that the Jersey region contributes significantly to the broader organizational goals. Through active leadership, Bovenizer drives regional engagement and supports the foundation's commitment to improving patient quality of life.

Julie Rommel, the Chapter President Emeritus at Crohn's & Colitis Foundation, provides historical context and advisory support to current leadership teams. Overseeing the continuity of the foundation's mission at the chapter level, the Chapter President Emeritus offers guidance on long-standing community engagement strategies and volunteer management. This role involves mentoring new leaders and ensuring that the organization maintains its core values while adapting to modern challenges in patient advocacy. By leveraging years of experience, Julie Rommel helps bridge the gap between past successes and future research goals. The Chapter President Emeritus participates in strategic discussions to ensure that regional initiatives remain aligned with the national mission of finding cures for inflammatory bowel diseases. Through ongoing dedication, Rommel supports the foundation's efforts to improve the quality of life for patients, providing a stable foundation for the next generation of leaders to build upon.

David Cecere, the Texas Board Member (North) & President, Oklahoma Chapter at Crohn's & Colitis Foundation, manages regional operations and advocacy initiatives across multiple states. Overseeing the development of local support networks, the Texas Board Member (North) & President, Oklahoma Chapter ensures that patients in these regions have access to essential resources and community programs. This role involves coordinating fundraising campaigns and building partnerships with local healthcare systems to advance the foundation's research mission. By fostering collaboration between the Texas and Oklahoma chapters, David Cecere maximizes the reach and effectiveness of the organization's services. The Texas Board Member (North) & President, Oklahoma Chapter works to increase awareness of Crohn's disease and ulcerative colitis, driving local participation in national research efforts. Through strategic regional leadership, Cecere ensures that the foundation's impact is felt across the southern United States, ultimately contributing to the discovery of effective treatments.

Nikki Pavone-Liberto, the President at Crohn's & Colitis Foundation, directs specific organizational initiatives focused on expanding patient outreach and community support. Overseeing the implementation of regional programs, the President ensures that the foundation's resources are effectively distributed to those in need. This role involves managing volunteer teams and coordinating with other executive leaders to align local activities with the national research agenda. By fostering strong connections within the patient community, Nikki Pavone-Liberto drives awareness and participation in critical fundraising events. The President works to ensure that the foundation's mission of improving the quality of life for individuals with Crohn's disease and ulcerative colitis remains a top priority in all regional operations. Through dedicated leadership and community engagement, Pavone-Liberto supports the organization's broader goal of finding cures, ensuring that patients receive the care and advocacy necessary to manage their conditions effectively.

Rohit Suri, the Chief Technology Officer at Crohn's & Colitis Foundation, architects the digital infrastructure required to support large-scale patient data management and research collaboration. Managing the integration of advanced software solutions, the Chief Technology Officer optimizes internal systems to streamline communication between medical researchers and the broader patient community. This role involves implementing secure data protocols to protect sensitive health information while enabling efficient access to educational resources. By leveraging modern technology platforms, Rohit Suri enhances the digital reach of the organization, facilitating better engagement with volunteers and donors across the United States. The Chief Technology Officer coordinates with other executive leaders to ensure that technological investments directly support the primary mission of finding cures. Suri maintains a focus on digital transformation, ensuring that the foundation remains at the forefront of medical non-profit innovation through scalable, reliable, and user-friendly technical solutions.

Orna Ehrlich, the Chief of Staff and Impact at Crohn's & Colitis Foundation, coordinates strategic initiatives that measure and maximize the organization's influence on patient health outcomes. Overseeing the alignment of internal programs with long-term impact goals, the Chief of Staff and Impact ensures that every project contributes meaningfully to the search for cures. This role involves facilitating communication between the executive team and the Board of Trustees to maintain focus on high-priority medical research and advocacy efforts. By analyzing program effectiveness and reporting on key performance indicators, Orna Ehrlich provides the data-driven insights necessary for informed decision-making. The Chief of Staff and Impact manages complex cross-functional projects that bridge the gap between scientific research and community support services. Through meticulous planning and execution, Ehrlich drives the foundation's ability to deliver tangible improvements in the lives of patients across the United States.

Marisa Mayer, the Chief Legal Officer at Crohn's & Colitis Foundation, directs all legal affairs, compliance, and risk management strategies for the organization. Overseeing the protection of intellectual property related to medical research, the Chief Legal Officer ensures that all partnerships and clinical collaborations adhere to strict regulatory standards. This role involves navigating complex non-profit governance requirements and managing contractual agreements with research institutions and corporate sponsors. By providing legal guidance on advocacy initiatives and fundraising activities, Marisa Mayer safeguards the reputation and financial integrity of the foundation. The Chief Legal Officer works with the executive team to mitigate operational risks while supporting the expansion of patient support services. Through proactive legal strategy, Mayer ensures that the organization remains compliant with federal and state laws, allowing the foundation to focus resources on the critical mission of finding cures for inflammatory bowel diseases.